183 related articles for article (PubMed ID: 16885153)
1. Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors.
Jie KE; Verhaar MC; Cramer MJ; van der Putten K; Gaillard CA; Doevendans PA; Koomans HA; Joles JA; Braam B
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F932-44. PubMed ID: 16885153
[TBL] [Abstract][Full Text] [Related]
2. [The cardiorenal syndrome and erythropoietin].
Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
[TBL] [Abstract][Full Text] [Related]
3. The severe cardiorenal syndrome: 'Guyton revisited'.
Bongartz LG; Cramer MJ; Doevendans PA; Joles JA; Braam B
Eur Heart J; 2005 Jan; 26(1):11-7. PubMed ID: 15615794
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal syndrome.
Mahapatra HS; Lalmalsawma R; Singh NP; Kumar M; Tiwari SC
Iran J Kidney Dis; 2009 Apr; 3(2):61-70. PubMed ID: 19395780
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study.
van der Putten K; Jie KE; Emans ME; Verhaar MC; Joles JA; Cramer MJ; Velthuis BK; Meiss L; Kraaijenhagen RJ; Doevendans PA; Braam B; Gaillard CA
J Nephrol; 2010; 23(4):363-8. PubMed ID: 20383871
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
van der Putten K; Braam B; Jie KE; Gaillard CA
Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
Palazzuoli A; Silverberg DS; Iovine F; Calabrò A; Campagna MS; Gallotta M; Nuti R
Am Heart J; 2007 Oct; 154(4):645.e9-15. PubMed ID: 17892986
[TBL] [Abstract][Full Text] [Related]
8. The interaction between heart failure and other heart diseases, renal failure, and anemia.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
[TBL] [Abstract][Full Text] [Related]
9. [The cardiorenal syndrome: an emerging renal disease].
Fabbian F
G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
[No Abstract] [Full Text] [Related]
10. [Cardiorenal syndrome, current understanding].
Ronco F; Ronco C
Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
[TBL] [Abstract][Full Text] [Related]
11. [The cardiorenal anemia syndrome and treatment with EPO].
Karle H; Hansen NE
Ugeskr Laeger; 2006 Aug; 168(33):2686. PubMed ID: 16953546
[No Abstract] [Full Text] [Related]
12. Erythropoietin and the heart: facts and perspectives.
Mastromarino V; Volpe M; Musumeci MB; Autore C; Conti E
Clin Sci (Lond); 2011 Jan; 120(2):51-63. PubMed ID: 20929439
[TBL] [Abstract][Full Text] [Related]
13. [Cardiorenal anemia syndrome (review)].
Minasyan A
Georgian Med News; 2012 Dec; (213):17-21. PubMed ID: 23293227
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
[TBL] [Abstract][Full Text] [Related]
15. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
16. [Fosinopril in the treatment of cardiorenal syndrome in chronic cardiac failure].
Tereshchenko SN; Zhirov IV
Ter Arkh; 2009; 81(5):84-8. PubMed ID: 19537594
[TBL] [Abstract][Full Text] [Related]
17. The potential role of erythropoietin in chronic heart failure: from the correction of anemia to improved perfusion and reduced apoptosis?
Timmer SA; De Boer K; Knaapen P; Götte MJ; Van Rossum AC
J Card Fail; 2009 May; 15(4):353-61. PubMed ID: 19398085
[TBL] [Abstract][Full Text] [Related]
18. Changes in kidney tissue and effects of erythropoietin after acute heart failure.
Güven Bağla A; Içkin Gülen M; Ercan F; Aşgün F; Ercan E; Bakar C
Biotech Histochem; 2018; 93(5):340-353. PubMed ID: 29671622
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of renal anemia.
Nangaku M; Eckardt KU
Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
[TBL] [Abstract][Full Text] [Related]
20. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
